The Interplay of Lipids, Lipoproteins, and Immunity in Atherosclerosis.

scientific article published on 14 February 2018

The Interplay of Lipids, Lipoproteins, and Immunity in Atherosclerosis. is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1101017636
P356DOI10.1007/S11883-018-0715-0
P2888exact matchhttps://scigraph.springernature.com/pub.10.1007/s11883-018-0715-0
P698PubMed publication ID29445885

P50authorAlberico L. CatapanoQ37841297
Angela PirilloQ38600937
P2093author name stringGiuseppe Danilo Norata
Fabrizia Bonacina
P2860cites workThe inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-betaQ24305136
Reduction of atherosclerosis in mice by inhibition of CD40 signallingQ24316540
Genetic Loci associated with C-reactive protein levels and risk of coronary heart diseaseQ24649709
Long-term activation of the innate immune system in atherosclerosisQ26750473
Transcriptional regulation of hepatic lipogenesisQ26778594
Dendritic cells in atherosclerosis: evidence in mice and humansQ28083158
Cholesterol, inflammation and innate immunityQ28086912
Critical role of caspase-1 in vascular inflammation and development of atherosclerosis in Western diet-fed apolipoprotein E-deficient miceQ57967556
Impaired serum cholesterol efflux capacity in rheumatoid arthritis and systemic lupus erythematosusQ60241027
Lack of Interleukin-1β Decreases the Severity of Atherosclerosis in ApoE-Deficient MiceQ62735862
The Inflammasome in Atherosclerosis and Type 2 DiabetesQ62818661
Lipoprotein receptors and the genetic control of cholesterol metabolism in cultured human cellsQ66843848
Oxidized low-density lipoprotein induces long-term proinflammatory cytokine production and foam cell formation via epigenetic reprogramming of monocytesQ88027071
Infections, atherosclerosis, and coronary heart diseaseQ89605356
CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammationQ28506984
Lactate Regulates Metabolic and Pro-inflammatory Circuits in Control of T Cell Migration and Effector FunctionsQ28546616
IL-18 overexpression promotes vascular inflammation and remodeling in a rat model of metabolic syndromeQ28574307
Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout miceQ28591350
Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant dataQ28742740
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statinsQ29547856
Thioredoxin-interacting protein links oxidative stress to inflammasome activationQ29614471
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystalsQ29615704
Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signalingQ29616024
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trialsQ29617910
Interleukin 18 binding protein (IL18-BP) inhibits neointimal hyperplasia after balloon injury in an atherosclerotic rabbit modelQ33331640
Macrophage ABCA1 reduces MyD88-dependent Toll-like receptor trafficking to lipid rafts by reduction of lipid raft cholesterol.Q34188006
Emerging role of high density lipoproteins as a player in the immune system.Q34202968
Reduced cholesterol absorption upon PPARdelta activation coincides with decreased intestinal expression of NPC1L1.Q34377352
Infusion of pharmaceutical-grade natural human C-reactive protein is not proinflammatory in healthy adult human volunteersQ34391885
Inflammation, metaflammation and immunometabolic disordersQ34550852
Low-density lipoprotein-dependent and -independent effects of cholesterol-lowering therapies on C-reactive protein: a meta-analysisQ34629713
Genetically elevated C-reactive protein and ischemic vascular diseaseQ34868720
Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasomeQ35006409
Effects of an antisense oligonucleotide inhibitor of C-reactive protein synthesis on the endotoxin challenge response in healthy human male volunteersQ35026389
Membrane microdomains and vascular biology: emerging role in atherogenesisQ35122046
Inhibition of CD40 signaling limits evolution of established atherosclerosis in miceQ35160907
ApoE regulates hematopoietic stem cell proliferation, monocytosis, and monocyte accumulation in atherosclerotic lesions in miceQ35370268
Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trialsQ35645239
LXRs link metabolism to inflammation through Abca1-dependent regulation of membrane composition and TLR signalingQ35896184
Cardiovascular disease and rheumatoid arthritis: an updateQ36218375
Role of cholesterol and lipid organization in diseaseQ36327808
Linking innate to adaptive immunity through dendritic cells.Q36728264
Sterol regulatory element-binding proteins are essential for the metabolic programming of effector T cells and adaptive immunityQ36839721
Lipid droplet-associated proteins in atherosclerosis (Review).Q36931267
LXR signaling couples sterol metabolism to proliferation in the acquired immune response.Q37061238
Functional role of CD11c+ monocytes in atherogenesis associated with hypercholesterolemiaQ37276351
Rationale and design of the Cardiovascular Inflammation Reduction Trial: a test of the inflammatory hypothesis of atherothrombosisQ37466366
Cholesterol crystals induce complement-dependent inflammasome activation and cytokine releaseQ37700323
Obesity-Induced Metabolic Stress Leads to Biased Effector Memory CD4+ T Cell Differentiation via PI3K p110δ-Akt-Mediated Signals.Q37707116
Revitalizing membrane rafts: new tools and insightsQ37791416
Anti-TNF-α agents in the treatment of immune-mediated inflammatory diseases: mechanisms of action and pitfallsQ37810960
HDLs, immunity, and atherosclerosis.Q37924543
Lipid rafts: a signalling platform linking lipoprotein metabolism to atherogenesisQ37954496
Inflammation and atherosclerosis: direct versus indirect mechanismsQ38077322
HDL in innate and adaptive immunity.Q38220759
Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients: The GLAGOV Randomized Clinical TrialQ38384675
Oxidized Phospholipids on Lipoprotein(a) Elicit Arterial Wall Inflammation and an Inflammatory Monocyte Response in HumansQ38389141
The Cellular and Molecular Basis of Translational Immunometabolism.Q38588211
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trialQ38601785
Antiinflammatory Therapy with Canakinumab for Atherosclerotic DiseaseQ38606033
Cholesterol crystal induced arterial inflammation and destabilization of atherosclerotic plaqueQ38679802
Trained immunity: A program of innate immune memory in health and disease.Q38814347
Lipid rafts in immune signalling: current progress and future perspective.Q38827777
Foamy monocytes form early and contribute to nascent atherosclerosis in mice with hypercholesterolemiaQ38860053
A novel CCR2 antagonist inhibits atherogenesis in apoE deficient mice by achieving high receptor occupancyQ38936733
Pleiotropic Effects of Statins on the Cardiovascular SystemQ39069187
Vascular inflammation and low-density lipoproteins: is cholesterol the link? A lesson from the clinical trialsQ39215606
Metabolic Instruction of Immunity.Q39286043
Frequency of Cholesterol Crystals in Culprit Coronary Artery Aspirate During Acute Myocardial Infarction and Their Relation to Inflammation and Myocardial Injury.Q40059965
Evolocumab and Clinical Outcomes in Patients with Cardiovascular DiseaseQ40287836
Location of major histocompatibility complex class II molecules in rafts on dendritic cells enhances the efficiency of T-cell activation and proliferationQ40332851
Postprandial Monocyte Activation in Individuals With Metabolic Syndrome.Q40467008
Overexpression of IL-18 decreases intimal collagen content and promotes a vulnerable plaque phenotype in apolipoprotein-E-deficient miceQ40506477
Concentration of MHC class II molecules in lipid rafts facilitates antigen presentationQ40820913
Bone marrow-specific caspase-1/11 deficiency inhibits atherosclerosis development in Ldlr(-/-) miceQ41147790
SREBP1 Contributes to Resolution of Pro-inflammatory TLR4 Signaling by Reprogramming Fatty Acid MetabolismQ41501239
The role of dendritic cells in T cell activation.Q41550864
Role of NLRP3 Inflammasomes in AtherosclerosisQ41787404
ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferationQ41789790
Regulation of hematopoietic stem and progenitor cell mobilization by cholesterol efflux pathways.Q41862465
CD11c/CD18 Signals Very Late Antigen-4 Activation To Initiate Foamy Monocyte Recruitment during the Onset of HypercholesterolemiaQ42629748
Linking lipid metabolism to the innate immune response in macrophages through sterol regulatory element binding protein-1a.Q42729920
Pharmacological inhibition of C-C chemokine receptor 2 decreases macrophage infiltration in the aortic root of the human C-C chemokine receptor 2/apolipoprotein E-/- mouse: magnetic resonance imaging assessmentQ43228817
Cholesterol Accumulation in CD11c+ Immune Cells Is a Causal and Targetable Factor in Autoimmune DiseaseQ44921258
Fatty acid-induced mitochondrial uncoupling elicits inflammasome-independent IL-1α and sterile vascular inflammation in atherosclerosisQ46323475
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trialQ47394886
Monocyte-Macrophages and T Cells in AtherosclerosisQ47632654
Silencing of CD40 in vivo reduces progression of experimental atherogenesis through an NF-κB/miR-125b axis and reveals new potential mediators in the pathogenesis of atherosclerosisQ47993155
HDL and ApoA-I inhibit antigen presentation-mediated T cell activation by disrupting lipid rafts in antigen presenting cells.Q52628286
Cholesterol Accumulation in Dendritic Cells Links the Inflammasome to Acquired Immunity.Q52772414
Abnormal CTLA-4 function in T cells from patients with systemic lupus erythematosusQ56899717
Darapladib for Preventing Ischemic Events in Stable Coronary Heart DiseaseQ57243317
P433issue3
P921main subjectatherosclerosisQ12252367
P304page(s)12
P577publication date2018-02-14
P1433published inCurrent Atherosclerosis ReportsQ20821076
P1476titleThe Interplay of Lipids, Lipoproteins, and Immunity in Atherosclerosis
P478volume20

Reverse relations

cites work (P2860)
Q92404808Circular RNA circ_0003204 inhibits proliferation, migration and tube formation of endothelial cell in atherosclerosis via miR-370-3p/TGFβR2/phosph-SMAD3 axis
Q98735442Dendritic Cells and T Cells, Partners in Atherogenesis and the Translating Road Ahead
Q90782102Early life feeding and current dietary patterns are associated with biomarkers of glucose and lipid metabolism in young women from the Nutritionist's Health Study
Q90015714Emerging techniques in atherosclerosis imaging
Q91925347HDL-C to hsCRP ratio is associated with left ventricular diastolic function in absence of significant coronary atherosclerosis
Q58788879Long noncoding RNA TCONS_00024652 regulates vascular endothelial cell proliferation and angiogenesis via microRNA-21
Q90737580Methotrexate Decreases the Level of PCSK9-A Novel Indicator of the Risk of Proatherogenic Lipid Profile in Psoriasis. The Preliminary Data
Q58706139Morning hypertension is a risk factor of macrovascular events following cerebral infarction: A retrospective study
Q97536508NLRP3 inflammasome via IL-1β regulates PCSK9 secretion
Q58701054Regulatory effect of Phikud Navakot extract on HMG-CoA reductase and LDL-R: potential and alternate agents for lowering blood cholesterol

Search more.